Abstract:Introduction: P38α is a mitogen-activated protein kinase (MAPK) that mediates inflammatory responses. P38α alterations have been associated with the inflammation-related diseases. However, the role of macrophages-derived p38α in dextran sulfate sodium (DSS)-induced murine experimental colitis remains unclear. Objectives: We characterized the role of macrophages-derived p38α in DSS-induced colitis. Methods: The expression of macrophage-derived p38α in human colitis and normal tissues was measured by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) analysis. Macrophage-specific p38α knockout (p38αΔMφ) and wild type (WT) mice administrated by 3% DSS were used to establish experimental colitis. The alterations in inflammatory cytokines, intestinal epithelial barrier, cell proliferation and cell apoptosis between p38αΔMφ and WT groups were determined by IHC, immunofluorescence (IF), TdT-mediated dUTP Nick-End Labeling (TUNEL) and Western blot analyses. The enriched pathways between p38αΔMφ and WT groups were identified by RNA-seq and KEGG analysis. SB203580 and BIRB796 as the p38 MAPK inhibitors were used to treat DSS-induced colitis. Results: p38α was co-localized with CD68 in the cytoplasm and their co-expression indicated an increased level in colitis tissues as compared with the normal tissues. P38α deficiency in macrophages was sufficient to suppress the exacerbated clinical symptoms and inflammation responses in experimental colitis, followed by reducing cytokine release, increasing MUC-2 and Claudin-2 secretion and promoting colonic mucosa repair. Further investigations validated that the immune process-related factors such as Lgals9, Rtp4, Ddx60, Nlrp1b, Hsh2d, Oas2 and Oas3 were upregulated in colon tissues from p38αΔMφ group as compared with the WT group. Inhibition of p38 MAPK attenuated DSS-induced colitis. Conclusion: Our findings demonstrated that p38α deficiency in macrophages ameliorated murine experimental colitis by regulating inflammation and immune process.

Protein Kinase P38α Signaling in Dendritic Cells Regulates Colon Inflammation and Tumorigenesis

Signaling Via the Kinase P38α Programs Dendritic Cells to Drive TH17 Differentiation and Autoimmune Inflammation.

P38α Signaling Programs Dendritic Cells to Drive TH17 Cell Differentiation and Function (48.14)

The kinase p38α functions in dendritic cells to regulate Th2-cell differentiation and allergic inflammation

Control of T Cell Fates and Immune Tolerance by P38α Signaling in Mucosal Dendritic Cells (P3177)

Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease.

Epithelial P38α Controls Immune Cell Recruitment in the Colonic Mucosa

Control of T Cell Fates and Immune Tolerance by P38α Signaling in Mucosal CD103+ Dendritic Cells.

P38α deficiency in macrophages ameliorates murine experimental colitis by regulating inflammation and immune process

Activation of P38α in T Cells Regulates the Intestinal Host Defense Against Attaching and Effacing Bacterial Infections

p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression

Distinct Effects of P38α Deletion in Myeloid Lineage and Gut Epithelia in Mouse Models of Inflammatory Bowel Disease

The Role of P38 Mitogen‐activated Protein Kinase in the Pathogenesis of Inflammatory Bowel Disease

[Role of P38 Mitogen-Activated Protein Kinase Pathway in Pathogenesis of Ulcerative Colitis].

P38α Has an Important Role in Antigen Cross-Presentation by Dendritic Cells.

The Study on Expression of P38 Mitogen-Activated Protein Kinases in Experimental Colitis

Effects of a selective p38 mitogen-activated protein kinase inhibitor on dextran sulphate sodium-induced colitis in mice

Inhibition of p38|[sol]|Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis

Signaling by the Phosphatase MKP-1 in Dendritic Cells Imprints Distinct Effector and Regulatory T Cell Fates

Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model

Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis